Last mentioned: Mar 24, 2026
BARDA Award Announced
Spectral AI receives $31.7 million to accelerate DeepView development.
Clinical Validation Phase
Planned acceleration of clinical trials and R&D activities funded by the award.
Spectral AI has been awarded $31.7 million from the Biomedical Advanced Research and Development Authority (BARDA) to accelerate the development and clinical validation of its DeepView® System. This non-dilutive funding supports the integration of AI-driven predictive analytics into burn and wound care, aiming to improve triage and treatment outcomes in both clinical and emergency response settings.
This page surfaces every story mentioning BARDA across our startup coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running startup beat. Cross-entity comparisons live on our compare view.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where BARDA was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |